FDANonrulemakingFDA-2019-D-1615

Who commented on this docket

Instructions for Use -- Patient Labeling for Human Prescription Drug and Biological Products and Drug-Device and Biologic-Device Combination Products -- Content and Format; Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on Instructions for Use -- Patient Labeling for Human Prescription Drug and Biological Products and Drug-Device and Biologic-Device Combination Products -- Content and Format; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 2520d ago.

Organizations
1
Comments
1
RIN
Comment window
closed 2520d ago

Commenters (1)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.